An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder

Journal of Psychopharmacology

Volumn 26, Issue 5, 2012, Pages 644-652

  Kessing, Lars Vedel ^a   Hellmund, Gunnar ^a   Andersen, Per Kragh ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Add on; bipolar disorder; hospitalization; lamotrigine; lithium; switch

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADD ON THERAPY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE SURVEILLANCE; DRUG EFFECT; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; MONOTHERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; REMISSION; SEX DIFFERENCE; TREATMENT DURATION; TREND STUDY;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COHORT STUDIES; FEMALE; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIAZINES;

EID: 84861818681     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111414091     Document Type: Article

References (36)

1. Altamura AC, Mundo E, Dell'Osso B, Tacchini G, Buoli M, Calabrese JR. Quetiapine and classical mood stabilizers in the long-term treatment of bipolar disorder: a 4-year follow-up naturalistic study. J Affect Disord. 2008 ; 110: 135-141
2. Andersen TF, Madsen M, Jorgensen J, Mellemkjaer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999 ; 46: 263-268
3. Baldessarini RJ. Treatment research in bipolar disorder: issues and recommendations. CNS Drugs. 2002 ; 16: 721-729
4. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv. 2007 ; 58: 85-91
5. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003 ; 60: 392-400
6. Calabrese JR, Kemp DE. Bipolar drug development: are we getting closer to the real world?. Am J Psychiatry. 2008 ; 165: 1234-1236
7. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003 ; 64: 1013-1024
8. Coryell W. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord. 2009 ; 11 (Suppl 2). 77-83
9. Danish National Board of Health (2002) Medicinal Product Statistics. Retrieved from http://laegemiddelstyrelsen.dk (accessed 21 September 2011).
10. Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry. 2009 ; 194: 4-9
11. Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet. 2010 ; 375: 385-395
12. Goldsmith DR, Wagstaff AJ, Ibbotson T, Perry CM. Lamotrigine: a review of its use in bipolar disorder. Drugs. 2003 ; 63: 2029-2050
13. Goodwin GM, Geddes JR. Latest maintenance data on lithium in bipolar disorder. Eur Neuropsychopharmacol. 2003 ; 13 (Suppl 2). S51 - S55
14. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009 ; 10: 85-116
15. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010 ; 11: 81-109
16. Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry. 2000 ; 12: 5-10
17. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull. 1999 ; 46: 354-357
18. Keitner GI, Posternak MA, Ryan CE. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial?. J Clin Psychiatry. 2003 ; 64: 1091-1093
19. KessingLVHellmundGGeddesJRGoodwinGMAndersenPK (2011) Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry199: 57-63.
20. Kessing LV, Sondergard L, Kvist K, Andersen PK. Suicide risk in patients treated with lithium. Arch Gen Psychiatry. 2005 ; 62: 860-866
21. Licht RW. Limitations in randomised controlled trials evaluating drug effects in mania. Eur Arch Psychiatry Clin Neurosci. 2001 ; 251 (Suppl 2). II66 - II71
22. Licht RW, Nielsen JN, Gram LF, Vestergaard P, Bendz H. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord. 2010 ; 12: 483-493
23. Licht RW, Vestergaard P, Kessing LV, Larsen JK, Thomsen PH. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr Scand Suppl. 2003 ; 419: 1-22
24. Malig C. The civil registration system in Denmark. 1996 ;:
25. Muller-Oerlinghausen B, Berghofer A, Ahrens B. The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Can J Psychiatry. 2003 ; 48: 433-439
26. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull. 1997 ; 44: 82-84
27. Muzina DJ, Elhaj O, Gajwani P, Gao K, Calabrese JR. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatr Scand Suppl. 2005 ; 426: 21-28
28. Partonen T, Sihvo S, Lonnqvist JK. Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry. 1996 ; 57: 572-575
29. Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. 2003 ; 64: 680-690
30. Reed C, Novick D, Gonzalez-Pinto A, Bertsch J, Haro JM. Observational study designs for bipolar disorder-what can they tell us about treatment in acute mania?. Prog Neuropsychopharmacol Biol Psychiatry. 2009 ; 33: 715-721
31. Schou M. Suicidal behavior and prophylactic lithium treatment of major mood disorders: a review of reviews. Suicide Life Threat Behav. 2000 ; 30: 289-293
32. Schou M. Lithium treatment at 52. J Affect Disord. 2001 ; 67: 21-32
33. Walden J, Schaerer L, Schloesser S, Grunze H. An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization. Bipolar Disord. 2000 ; 2: 336-339
34. ATC index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology ; 2003 :
35. Klassifikation af sygdomme. Systematisk del. International Statistical Classification of Diseases and Health Related Problems. Copenhagen: World Health Organisation ; 1993 :
36. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?. Am J Psychiatry. 2002 ; 159: 469-473